NEUROPACE INC (NPCE) Fundamental Analysis & Valuation

NASDAQ:NPCE • US6412881053

Current stock price

13.98 USD
-0.21 (-1.48%)
Last:

This NPCE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NPCE Profitability Analysis

1.1 Basic Checks

  • In the past year NPCE has reported negative net income.
  • NPCE had a negative operating cash flow in the past year.
  • In the past 5 years NPCE always reported negative net income.
  • NPCE had a negative operating cash flow in each of the past 5 years.
NPCE Yearly Net Income VS EBIT VS OCF VS FCFNPCE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

  • With a Return On Assets value of -20.33%, NPCE perfoms like the industry average, outperforming 48.91% of the companies in the same industry.
  • NPCE's Return On Equity of -112.79% is on the low side compared to the rest of the industry. NPCE is outperformed by 65.22% of its industry peers.
Industry RankSector Rank
ROA -20.33%
ROE -112.79%
ROIC N/A
ROA(3y)-26.54%
ROA(5y)-29.58%
ROE(3y)-203.69%
ROE(5y)-159.09%
ROIC(3y)N/A
ROIC(5y)N/A
NPCE Yearly ROA, ROE, ROICNPCE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 200 -200

1.3 Margins

  • The Gross Margin of NPCE (77.23%) is better than 89.13% of its industry peers.
  • NPCE's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for NPCE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.66%
GM growth 5Y0.97%
NPCE Yearly Profit, Operating, Gross MarginsNPCE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. NPCE Health Analysis

2.1 Basic Checks

  • NPCE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • NPCE has more shares outstanding than it did 1 year ago.
  • NPCE has more shares outstanding than it did 5 years ago.
  • NPCE has a better debt/assets ratio than last year.
NPCE Yearly Shares OutstandingNPCE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
NPCE Yearly Total Debt VS Total AssetsNPCE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -2.77, we must say that NPCE is in the distress zone and has some risk of bankruptcy.
  • NPCE has a worse Altman-Z score (-2.77) than 65.22% of its industry peers.
  • A Debt/Equity ratio of 3.09 is on the high side and indicates that NPCE has dependencies on debt financing.
  • The Debt to Equity ratio of NPCE (3.09) is worse than 85.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.09
Debt/FCF N/A
Altman-Z -2.77
ROIC/WACCN/A
WACC10.36%
NPCE Yearly LT Debt VS Equity VS FCFNPCE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M

2.3 Liquidity

  • NPCE has a Current Ratio of 5.28. This indicates that NPCE is financially healthy and has no problem in meeting its short term obligations.
  • NPCE has a better Current ratio (5.28) than 78.26% of its industry peers.
  • NPCE has a Quick Ratio of 4.33. This indicates that NPCE is financially healthy and has no problem in meeting its short term obligations.
  • NPCE has a better Quick ratio (4.33) than 76.09% of its industry peers.
Industry RankSector Rank
Current Ratio 5.28
Quick Ratio 4.33
NPCE Yearly Current Assets VS Current LiabilitesNPCE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. NPCE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 30.53% over the past year.
  • The Revenue has grown by 25.13% in the past year. This is a very strong growth!
  • The Revenue has been growing by 19.44% on average over the past years. This is quite good.
EPS 1Y (TTM)30.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.56%
Revenue 1Y (TTM)25.13%
Revenue growth 3Y29.99%
Revenue growth 5Y19.44%
Sales Q2Q%23.86%

3.2 Future

  • The Earnings Per Share is expected to grow by 20.65% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 16.68% on average over the next years. This is quite good.
EPS Next Y-16.79%
EPS Next 2Y18.34%
EPS Next 3Y30.38%
EPS Next 5Y20.65%
Revenue Next Year0.28%
Revenue Next 2Y12.17%
Revenue Next 3Y17.02%
Revenue Next 5Y16.68%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
NPCE Yearly Revenue VS EstimatesNPCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
NPCE Yearly EPS VS EstimatesNPCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

1

4. NPCE Valuation Analysis

4.1 Price/Earnings Ratio

  • NPCE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year NPCE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NPCE Price Earnings VS Forward Price EarningsNPCE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NPCE Per share dataNPCE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • NPCE's earnings are expected to grow with 30.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.34%
EPS Next 3Y30.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NPCE Dividend Analysis

5.1 Amount

  • No dividends for NPCE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NPCE Fundamentals: All Metrics, Ratios and Statistics

NEUROPACE INC

NASDAQ:NPCE (3/17/2026, 1:30:05 PM)

13.98

-0.21 (-1.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-03
Earnings (Next)05-11
Inst Owners76%
Inst Owner Change4.74%
Ins Owners2.49%
Ins Owner Change-0.12%
Market Cap462.46M
Revenue(TTM)99.99M
Net Income(TTM)-21.46M
Analysts84.29
Price Target19.89 (42.27%)
Short Float %3.18%
Short Ratio3.63
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)46.63%
Min EPS beat(2)45.05%
Max EPS beat(2)48.21%
EPS beat(4)3
Avg EPS beat(4)23.35%
Min EPS beat(4)-14.56%
Max EPS beat(4)48.21%
EPS beat(8)7
Avg EPS beat(8)20.29%
EPS beat(12)11
Avg EPS beat(12)21.64%
EPS beat(16)13
Avg EPS beat(16)16.38%
Revenue beat(2)2
Avg Revenue beat(2)7%
Min Revenue beat(2)5.14%
Max Revenue beat(2)8.86%
Revenue beat(4)3
Avg Revenue beat(4)3.74%
Min Revenue beat(4)-0.11%
Max Revenue beat(4)8.86%
Revenue beat(8)6
Avg Revenue beat(8)3.56%
Revenue beat(12)10
Avg Revenue beat(12)7.31%
Revenue beat(16)13
Avg Revenue beat(16)5.83%
PT rev (1m)0%
PT rev (3m)11.43%
EPS NQ rev (1m)-2.07%
EPS NQ rev (3m)-5.71%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.85%
Revenue NQ rev (1m)-1.13%
Revenue NQ rev (3m)-2.08%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.63
P/FCF N/A
P/OCF N/A
P/B 24.3
P/tB 24.3
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)-0.77
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS3.02
BVpS0.58
TBVpS0.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.33%
ROE -112.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.23%
FCFM N/A
ROA(3y)-26.54%
ROA(5y)-29.58%
ROE(3y)-203.69%
ROE(5y)-159.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.66%
GM growth 5Y0.97%
F-Score5
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 3.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 139.5%
Cap/Sales 0.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.28
Quick Ratio 4.33
Altman-Z -2.77
F-Score5
WACC10.36%
ROIC/WACCN/A
Cap/Depr(3y)129.3%
Cap/Depr(5y)147.36%
Cap/Sales(3y)0.33%
Cap/Sales(5y)0.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.56%
EPS Next Y-16.79%
EPS Next 2Y18.34%
EPS Next 3Y30.38%
EPS Next 5Y20.65%
Revenue 1Y (TTM)25.13%
Revenue growth 3Y29.99%
Revenue growth 5Y19.44%
Sales Q2Q%23.86%
Revenue Next Year0.28%
Revenue Next 2Y12.17%
Revenue Next 3Y17.02%
Revenue Next 5Y16.68%
EBIT growth 1Y24.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.63%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y37.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y38.68%
OCF growth 3YN/A
OCF growth 5YN/A

NEUROPACE INC / NPCE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NEUROPACE INC?

ChartMill assigns a fundamental rating of 3 / 10 to NPCE.


What is the valuation status of NEUROPACE INC (NPCE) stock?

ChartMill assigns a valuation rating of 1 / 10 to NEUROPACE INC (NPCE). This can be considered as Overvalued.


How profitable is NEUROPACE INC (NPCE) stock?

NEUROPACE INC (NPCE) has a profitability rating of 1 / 10.


What is the expected EPS growth for NEUROPACE INC (NPCE) stock?

The Earnings per Share (EPS) of NEUROPACE INC (NPCE) is expected to decline by -16.79% in the next year.